Literature DB >> 6466573

Natural killer-interferon system in patients with preleukaemic states.

S Takagi, S Kitagawa, A Takeda, N Minato, F Takaku, Y Miura.   

Abstract

The natural killer (NK)-interferon (IFN) system was investigated in patients with preleukaemic states. Endogenous NK cell activity was markedly reduced in all 12 patients studied. No significant correlation was observed between the activity of NK cells and the percentage of blast cells in the peripheral blood or bone marrow. The frequency of large granular lymphocytes (LGL) in lymphocytes of the peripheral blood was not reduced in most patients. The percentage of target binding cells in patients was essentially the same as that in normal controls, and the activity of NK cells from normal donors was not affected by the coexistence of mononuclear cells obtained from the peripheral blood of patients. Furthermore, the alpha-IFN production in response to HeLa cells persistently infected with measles virus was reduced in all patients studied, except for one case with acquired idiopathic sideroblastic anaemia. The augmented activity of NK cells induced by alpha-IFN was variable, but remained at lower levels than the endogenous activity of NK cells in normal controls. These findings suggest that not only the intrinsic defect and reduced number of NK cells but also the dysfunction of the NK-IFN system may be responsible for the reduced activity of NK cells in patients with preleukaemic states.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466573     DOI: 10.1111/j.1365-2141.1984.tb06060.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients.

Authors:  M N Satam; J N Suraiya; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.

Authors:  Dragomir Marisavljević; Nada Kraguljac; Zoran Rolović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Defects of natural killer cell activity in children with untreated acute lymphocytic leukemia.

Authors:  J Gabrilovac; M Boranić; B Kusić; D Batinić; L Rajić; A Tiefenbach
Journal:  Klin Wochenschr       Date:  1988-04-15

4.  Normal natural killer cell activity in Hodgkin's disease patients in remission.

Authors:  D Douer; N Shaked; B Ramot
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

5.  Lymphokine-activated killer cytotoxicity against leukaemic blast cells.

Authors:  J A Tratkiewicz; J Szer; R L Boyd
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

Review 6.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

7.  Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.

Authors:  Pearlie K Epling-Burnette; Fanqi Bai; Jeffrey S Painter; Dana E Rollison; Helmut R Salih; Matthias Krusch; Jianxiang Zou; Edna Ku; Bin Zhong; David Boulware; Lynn Moscinski; Sheng Wei; Julie Y Djeu; Alan F List
Journal:  Blood       Date:  2007-03-06       Impact factor: 22.113

8.  The effect of recombinant alpha-interferon on natural killer cell activity and clinical course in patients with myelodysplastic syndrome.

Authors:  X Yataganas; G Eliopoulos; S Koulocheri; N Viniou; E Plata; P Panagiotidis; G Vayopoulos; J Meletis; P Fessas
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

Review 9.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.